
Pasixone SB 250mg/125mg Injection
Marketer
Passim Medica
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Pasixone SB 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under a doctor's guidance; missed doses should be avoided, and the prescribed course completed regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Allergic reactions (rash, itching, edema, dyspnea) necessitate urgent medical care. Inform your physician of all current medications, particularly if pregnant or breastfeeding, before initiating treatment. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your physician may order tests to monitor treatment response.
Uses of Pasixone SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Pasixone SB 250mg/125mg Injection:
The medication will be administered by your physician or registered nurse; please do not attempt self-medication.
Common Side effects of Pasixone SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Pasixone SB 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Please refrain from self-medication.
How Pasixone SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Pasixone SB 250mg/125mg Injection, offer targeted antibacterial action. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Pasixone SB 250mg/125mg Injection does not produce adverse reactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Pasixone SB 250mg/125mg is usually deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nonetheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Pasixone SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Pasixone SB 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Pasixone SB 250mg/125mg Injection use in patients with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
For individuals with severe hepatic impairment, Pasixone SB 250mg/125mg Injection requires careful administration and potential dosage modification. Patients with mild to moderate liver disease, however, do not typically require dosage alteration of Pasixone SB 250mg/125mg Injection. Physician consultation is advised.
What if you forget to take Pasixone SB 250mg/125mg Injection :
Omitting a scheduled dose of Pasixone SB 250mg/125mg Injection necessitates contacting your physician.
Facts to Know About Pasixone SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
